So maybe can you expand on like, cause there was just the first trial, right? I mean, can you expand on that? And then, which I know you mentioned on the last show, but then also mentioned kind of what's been new since the last podcast, kind of the current clinical trials as well.
What we did was we looked, started with other people with progressive MS and They're no longer relapsing or remitting.
They're in the phase where you just get the steady decline, 10% to 15% in each domain every year.
And the intervention was the same supplement list that I was taking, the electrostimulation using the same device I was using.
Then we also measured walking, 25 feet, nine-hole pegboard, hand function, and some working memory.
So maybe can you expand on like, cause there was just the first trial, right? I mean, can you expand on that? And then, which I know you mentioned on the last show, but then also mentioned kind of what's been new since the last podcast, kind of the current clinical trials as well.
What we did was we looked, started with other people with progressive MS and They're no longer relapsing or remitting.
They're in the phase where you just get the steady decline, 10% to 15% in each domain every year.
And the intervention was the same supplement list that I was taking, the electrostimulation using the same device I was using.
Then we also measured walking, 25 feet, nine-hole pegboard, hand function, and some working memory.
The rest of this transcript — segmented and speaker-labeled, so you land on the exact moment something was said
Search every transcript — by keyword, by phrase, or by meaning, across every show Radar indexes
Trends — what is surging across podcasts, measured against its own baseline
Alerts — when a name you follow appears in a newly indexed episode
No account is needed to search Radar.